文献速递生殖医学

口服抗生素治疗慢性子宫内膜炎对冻融胚胎移植妊娠结局的影响:640个周期的队列研究

Impact of oral antibiotic treatment for chronic endometritis on pregnancy outcomes in the following frozen-thawed embryo transfer cycles of infertile women: a cohort study of 640 embryo transfer cycles.
PubMed 文献 · Fertil Steril · 2021-04-26

这项回顾性队列研究纳入640例不孕女性,按首次子宫内膜CD138+/HPF分为0、1-4和≥5三组,≥5组口服抗生素治疗后复查,26例诊断为持续性慢性子宫内膜炎(PCE)。CD138+/HPF≤4者妊娠结局不受影响,≥5组治愈率89.0%;CD138+/HPF≤4者种植率、临床妊娠率、活产率和累积活产率均显著高于PCE者。

要点

  • CD138+/HPF≤4对冻融胚胎移植妊娠结局无负面影响
  • CD138+/HPF≥5者抗生素治疗后治愈率89.0%
  • PCE与较差的妊娠结局相关,CD138+/HPF≤4者结局优于PCE

核心结论

  • 子宫内膜CD138+/HPF≤4对妊娠结局无负面影响。
  • 抗生素治疗可有效改善CD138+/HPF≥5女性的生殖结局。
  • 持续性慢性子宫内膜炎(PCE)与较差的妊娠结局相关。

研究设计与样本

  • 回顾性研究,纳入640例不孕女性共640个冻融胚胎移植周期。
  • 首次评估子宫内膜CD138+/HPF:0者88例,1-4者315例,≥5者237例。
  • 237例中26例诊断为持续性慢性子宫内膜炎(PCE)。
  • 增殖期行宫腔镜和子宫内膜活检,抗生素治疗后再次活检。

主要发现

  • CD138+/HPF=0与1-4组间妊娠结局无显著差异。
  • CD138+/HPF≥5者抗生素治疗后治愈率为89.0%。
  • CD138+/HPF≤4者较PCE者种植率更高(51.6% vs. 32.3%,RR 2.23,95%CI 1.07-4.66)。
  • CD138+/HPF≤4者较PCE者临床妊娠率更高(65.7% vs. 42.3%,RR 2.62,95%CI 1.17-5.86)。
  • CD138+/HPF≤4者较PCE者活产率更高(52.1% vs. 30.7%,RR 2.45,95%CI 1.04-5.76),累积活产率更高(64.2% vs. 38.5%,RR 2.88,95%CI 1.27-6.51)。

临床怎么用

  • 对CD138+/HPF≥5的不孕女性,可考虑口服抗生素治疗以改善冻融胚胎移植结局。
  • CD138+/HPF≤4者无需因慢性子宫内膜炎诊断而延迟冻融胚胎移植。
  • 治疗后持续CD138+/HPF≥5(PCE)者妊娠结局较差,需进一步评估和管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the therapeutic effect of antibiotic treatment on pregnancy outcomes in the following frozen-thawed embryo transfer cycles of infertile women. DESIGN: Retrospective study. SETTING: University assisted reproduction unit. PATIENT(S): A total of 640 women were included. Among them, the number of CD138+ cells per high-power field (CD138+/HPF) in the endometrium at the first evaluation was 0 in 88 women; 315 women had 1-4 CD138+/HPF and the remaining 237 had ≥5 CD138+/HPF. Finally, 26 of 237 women had persistent chronic endometritis (PCE) diagnosed. INTERVENTION(S): Hysteroscopy and endometrial biopsy were performed in the proliferative phase. After antibiotic treatment, endometrial biopsy samples were collected again. MAIN OUTCOME MEASURE(S): Live birth rate. RESULT(S): No significant difference in pregnancy outcomes was found between women with CD138+/HPF = 0 and those with CD138+/HPF 1-4. The cure rate was 89.0% in women with CD138+/HPF ≥5 after treatment. The implantation rate (51.6% vs. 32.3%, relative risk [RR] 2.23, 95% confidence interval [CI] 1.07-4.66), clinical pregnancy rate (65.7% vs. 42.3%, RR 2.62, 95% CI 1.17-5.86), live birth rate (52.1% vs. 30.7%, RR 2.45, 95% CI 1.04-5.76), and cumulative live birth rate (64.2% vs. 38.5%, RR 2.88, 95% CI 1.27-6.51) were all significantly higher in women with CD138+/HPF ≤4 than in women with PCE. CONCLUSION(S): CD138+/HPF ≤4 in the endometrium had no negative impact on pregnancy outcomes. Antibiotic treatment was an effective way to improve the reproductive outcomes of women with CD138+/HPF ≥5. PCE was associated with poorer pregnancy outcomes.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Xiong Y, Chen Q, Chen C, et al. Impact of oral antibiotic treatment for chronic endometritis on pregnancy outcomes in the following frozen-thawed embryo transfer cycles of infertile women: a cohort study of 640 embryo transfer cycles. Fertil Steril. 2021. PMID: 33926717. doi:10.1016/j.fertnstert.2021.03.036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。